Author:
Neškovié-Konstantinovié Z.,Mitrovié L.,Petrovié J.,Stamatovié L.,Ristovié Z.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Body JJ, Dumon JC (1994) Treatment of tumor-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumor type. Ann Oncol 5:359–363
2. Body JJ, Borkowski A, Cleeren A, Bijvoet OLM (1986) Treatment of malignancy-associated hypercalcaemia with intravenous aminohydroxypropylidene diphosphonate. Clin Oncol 4:1177–1183
3. Cohen AL, Koeller J, Davis TE, Citrin DL (1981) I.V. dichloromethylene diphosphonate in cancer-associated hypercalcaemia: a phase I–II evaluation. Cancer Treat Rep 65:651–653
4. Kanis JA, McCloskey EV, Traube T, O'Rourke N (1991) Rationale for the use of bisphosphonates in bone metastases. Bone 12 [Suppl 1]:S13-S18
5. Ralston SH (1991) Pathogenesis and management of cancer-associated hypercalcaemia. In: Rubens RD, Fogelman I (eds) Bone metatsases — diagnosis and treatment. Springer, London, pp 149–169
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献